US Patent Issued to Escient Pharmaceuticals on April 15 for "Modulators of mas-related g-protein receptor X2 and related products and methods" (California Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,707, issued on April 15, was assigned to Escient Pharmaceuticals Inc. (San Diego).

"Modulators of mas-related g-protein receptor X2 and related products and methods" was invented by Marion Lanier (San Diego), Marcus Boehm (San Diego), Liming Huang (San Diego), Esther Martinborough (San Diego), Marcos Sainz (San Diego), Brandon Selfridge (San Diego) and Adam Yeager (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for modulating MRGPR X2 generally, or for treating a MRGPR X2 or a MRGPR X2 ortholog dependent condition, more specifically, by contacting the MRGPR X2 or the MRGPR X2 ortholog by administering to a subject in ne...